Figure 2 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
<p>ART558 treatment leads to increased residual IR-induced DNA damage foci. <b>A,</b> γH2AX and 53BP1 foci in HCT116 and H460 cells treated with 3 μmol/L ART558 and 4 Gy IR, assessed at the indicated times points after IR. <b>B,</b> Representative images from irradiated...
Uloženo v:
Podobné jednotky
-
Figure 1 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Autor: Gonzalo Rodriguez-Berriguete (15056057)
Vydáno: (2025) -
Figure 3 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Autor: Gonzalo Rodriguez-Berriguete (15056057)
Vydáno: (2025) -
Figure 4 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Autor: Gonzalo Rodriguez-Berriguete (15056057)
Vydáno: (2025) -
Figure 5 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Autor: Gonzalo Rodriguez-Berriguete (15056057)
Vydáno: (2025) -
Supplementary Table S1 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Autor: Gonzalo Rodriguez-Berriguete (15056057)
Vydáno: (2025)